Novo Nordisk A/S left open the door for additional work on its pill version of Ozempic for Alzheimer’s disease after a pair ...

Experts say we’re in a golden age for treating chronic kidney disease, with new drugs like Ozempic yielding major results. Will dialysis and organ transplants become a thing of the past? A healthy ...

The next-generation “GLP-1 plus” drugs will be tailored to the health needs of individual patients.

Orforglipron is Lilly’s oral GLP-1 in phase 3 development as a treatment for diabetes and obesity. The FDA is expected to approve the drug in March 2026. Lilly’s November news release states that the ...

Novo Nordisk is cutting the out-of-pocket prices of its popular weight-loss drug Wegovy and diabetes drug Ozempic for some consumers. Current customers who pay for the drugs out of pocket — without ...

The drugmaker said it has started selling higher doses of the injectable treatment for $349 a month to patients paying the full bill.

Semaglutide is the active ingredient in Wegovy ® and Ozempic ® and, unlike any other molecule in the GLP-1 class, has FDA-approved medicines with indications for patients with obesity (Wegovy ®), type ...

LONDON, Nov 12 (Reuters) - Generic drugmaker Sandoz (SDZ.S), opens new tab expects unbranded versions of Novo Nordisk's (NOVOb.CO), opens new tab blockbuster diabetes drug Ozempic to launch in Canada ...

These medications may be influencing fertility in ways scientists are only beginning to understand. Developed for diabetes, GLP-1 drugs have become popular for weight loss. Researchers are ...

Listen to more stories on the Noa app. Donald Trump was giddy. In the Oval Office today, the president announced that he had secured a deal to dramatically slash the price of obesity drugs. Soon, ...

Some people taking popular new diabetes and weight-loss drugs including Ozempic, Wegovy, Zepbound and Mounjaro have reported reduced cravings for substances besides food. The medications seem to ...